This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

QBX258

Novartis AG

Drug Names(s): VAK649 + QAX576

Description: QBX258 is a combination product of VAK694, an antibody against IL-4, and QAX576, a monoclonal antibody targeting interleukin-13 (IL-13).


QBX258 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug